Showing results (1091-1100 of 1,170) with videos related to

Sort By:
Pageof 117
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 15, 2025
Interventional Cardiologists' Perspectives on Percutaneous Coronary Intervention at Ambulatory Surgical CentersThomas R Basala, Michaella Alexandrou, Dimitrios Strepkos, et al.
ACS Chemical Biology|July 2, 2025
Mediator Kinase Inhibitor Selectivity and Activity in Colorectal CancerMaria J Ortiz-Ruiz, Olajumoke Popoola, Konstantinos Mitsopoulos, et al.
Journal of Medicinal Chemistry|June 23, 2010
Imidazo[4,5-b]pyridine derivatives as inhibitors of Aurora kinases: lead optimization studies toward the identification of an orally bioavailable preclinical development candidateVassilios Bavetsias, Jonathan M Large, Chongbo Sun, et al.
Viruses|January 8, 2025
Assessment of Favipiravir and Remdesivir in Combination for SARS-CoV-2 Infection in Syrian Golden HamstersMegan Neary, Eduardo Gallardo-Toledo, Joanne Sharp, et al.
Oncogene|June 1, 2019
Correction: Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancerSteve Wagner, Georgios Vlachogiannis, Alexis De Haven Brandon, et al.
Cancer Research|March 3, 2007
In vitro biological characterization of a novel, synthetic diaryl pyrazole resorcinol class of heat shock protein 90 inhibitorsSwee Y Sharp, Kathy Boxall, Martin Rowlands, et al.
Molecular Oncology|December 1, 2021
FGF7-FGFR2 autocrine signaling increases growth and chemoresistance of fusion-positive rhabdomyosarcomasChristopher I Milton, Joanna Selfe, Ewa Aladowicz, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
Targeting CREB remodels the immune microenvironment to enhance immunotherapy responses in pancreatic cancerSiddharth Mehra, Supriya Srinivasan, Sudhakar Jinka, et al.
Rheumatology (Oxford, England)|October 20, 2019
A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritisCynthia Aranow, John Cush, Marcy B Bolster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 30, 2012
CCT244747 is a novel potent and selective CHK1 inhibitor with oral efficacy alone and in combination with genotoxic anticancer drugsMike I Walton, Paul D Eve, Angela Hayes, et al.
Pageof 117